Find CMO/CDMOs that produce: Biologics
Biosimilars
Category
Filters
Reset current filters
Selected filters:
Production region
Production scale
Qualifications
CDMO-CMO
Catalent
Biosimilars production
Pioneering in advanced delivery technologies and development solutions.
Extensive global network ensuring supply chain resilience.
Tailored services across biologics, gene therapies, and pharmaceuticals.
All certificates
Replies slower than most
CDMO-CMO
Kindeva
Biosimilars production
Leading in aerosol and transdermal drug delivery systems.
Expertise in both small molecule and biologic drug formulation.
Strong track record in bringing complex therapies to market.
All certificates
Replies slower than most
Follow us
CDMO-CMO
Shilpa Medicare Ltd
Biosimilars production
Plants in:
Established in: 1989
Production scale:
large
Employees: 5000+
6 production facilities approved by USFDA, AGES-Austria, PMDA, WHO
R&D Centers with capabilities of ANDAs, DMFs and NDDS
462+ patents filed for drug substances and polymorphs
All certificates
Replies quickly
CDMO-CMO
Boehringer Ingelheim Group
Biosimilars production
Strong heritage in pharmaceutical innovation and biotechnology.
Comprehensive range of services from early development to commercial supply.
Focus on quality, reliability, and sustainability in biopharmaceutical manufacturing.
All certificates
Replies slower than most
CDMO-CMO
Argonaut Manufacturing Services Inc.
Biosimilars production
Plants in:
Established in: 2016
Production scale:
medium
small
Low Volume high value API Fill and Finish Service
In-line monitoring, SKAN Isolators, Highly Experienced Staff
Capacity Available, Ready for your API
All certificates
Replies quickly
CDMO-CMO
Alcami
Biosimilars production
Successfully inspected by TGA, PMDA, MHRA, ANVISA, Health Canada, MPA, IMB, & FDA
All facilities are in good standing with all regulatory authorities, including DEA, EPA, OSHA
Quality Management System and supporting analytical processes are almost 100% electronic
All certificates
Replies quickly
CDMO-CMO
KBI Biopharma
Biosimilars production
Plants in:
Established in: 1996
Production scale:
large
small
medium
Leading in biopharmaceutical development and biologic API production.
Comprehensive services from cell line development to commercial manufacturing.
Strong track record in delivering complex and high-quality biologics.
All certificates
Contact supplier
Not active
Looking for CMO/CDMO Services?
Find a list of providers specializing in CMOs/CDMOs Services for Biosimilars. Navigate through our extensive selection to identify the supplier that aligns with your specific needs.
Pharmaoffer makes it easy and convenient to send inquiries at no cost. Directly connect with your chosen supplier and take the first step towards fulfilling your pharmaceutical needs easily and efficiently.
CMO/CDMO - Contract (Development) Manufacturing Organizations
CDMOs and CMOs are pivotal in the pharmaceutical and biotech industries, offering specialized services in drug development and manufacturing. They assist in scaling up production from laboratory to commercial quantities, while adhering to strict regulatory standards. These organizations play a crucial role in the efficient and cost-effective production of medical and pharmaceutical products, ensuring quality and compliance at every stage.
Biologics
Biologics CMOs/CDMOs specialize in the manufacturing and development of biopharmaceutical products, which are typically derived from living organisms or biological sources such as proteins, antibodies, vaccines, and cell therapies.
Biosimilars
Biosimilars are an emerging field in pharmaceuticals, offering cost-effective alternatives to biologics. Their development requires demonstrating similarity in efficacy and safety, involving complex analytical and clinical studies, crucial for expanding access to biologic therapies.
Pharmaoffer showcases a selection of Contract Development and Manufacturing Organizations (CDMOs) specializing in Biosimilars. This emerging field in pharmaceuticals provides cost-effective alternatives to original biologic therapies, including Biosimilar Development, Biosimilar Drug Manufacturing, and Biosimilar Production. Our platform connects pharmaceutical professionals with CDMOs experienced in the intricate process of biosimilar development.
Key Services Provided by Our Listed CDMOs:
Analytical Similarity Assessment: Comprehensive analytical studies to establish biosimilarity, focusing on molecular characterization, biological activity, and immunochemical properties. This is a key component of Biosimilar Development.
Clinical Development Expertise: Rigorous clinical trials to demonstrate equivalent efficacy and safety profiles compared to reference biologics. This expertise is vital in Biosimilar Drug Manufacturing.
Regulatory Strategy and Compliance: In-depth knowledge of regulatory pathways and standards, ensuring compliance with agencies such as the FDA and EMA for biosimilar approval.
Manufacturing Scale-Up: Capability to scale up biosimilar production, maintaining consistency and quality from lab-scale to commercial batches. This scalability is essential in Biosimilar Production.
Tailored Biosimilar Solutions: Custom development services for a wide range of biosimilar products, addressing various therapeutic areas.
Find Your Biosimilar Development Partner
On Pharmaoffer, pharmaceutical professionals can easily find and connect with CDMOs that have a proven track record in biosimilar development and manufacturing. Our platform ensures you have access to CDMOs that are committed to expanding access to biologic therapies through high-quality, cost-effective biosimilar products.
